DE69535210D1 - Pharmazeutische Zusammensetzung enthaltend 2,3-Alkylcarbonyloxybenzoesäure und Ibuprofen - Google Patents

Pharmazeutische Zusammensetzung enthaltend 2,3-Alkylcarbonyloxybenzoesäure und Ibuprofen

Info

Publication number
DE69535210D1
DE69535210D1 DE69535210T DE69535210T DE69535210D1 DE 69535210 D1 DE69535210 D1 DE 69535210D1 DE 69535210 T DE69535210 T DE 69535210T DE 69535210 T DE69535210 T DE 69535210T DE 69535210 D1 DE69535210 D1 DE 69535210D1
Authority
DE
Germany
Prior art keywords
ibuprofen
pharmaceutical composition
composition containing
alkylcarbonyloxybenzoic acid
alkylcarbonyloxybenzoic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69535210T
Other languages
English (en)
Other versions
DE69535210T2 (de
Inventor
T Flavin
J Nelson
F Borgia
J Jesmok
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Advanced Life Sciences Inc
Original Assignee
Advanced Life Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Life Sciences Inc filed Critical Advanced Life Sciences Inc
Application granted granted Critical
Publication of DE69535210D1 publication Critical patent/DE69535210D1/de
Publication of DE69535210T2 publication Critical patent/DE69535210T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69535210T 1994-12-30 1995-12-21 Pharmazeutische Zusammensetzung enthaltend 2,3-Alkylcarbonyloxybenzoesäure und Ibuprofen Expired - Fee Related DE69535210T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/366,885 US5504111A (en) 1994-12-30 1994-12-30 Use of 2,3 alkylcarbonyloxybenzoic acid in treating adult respiratory distress syndrome
US366885 1994-12-30

Publications (2)

Publication Number Publication Date
DE69535210D1 true DE69535210D1 (de) 2006-10-12
DE69535210T2 DE69535210T2 (de) 2007-08-02

Family

ID=23444992

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69535210T Expired - Fee Related DE69535210T2 (de) 1994-12-30 1995-12-21 Pharmazeutische Zusammensetzung enthaltend 2,3-Alkylcarbonyloxybenzoesäure und Ibuprofen
DE69530120T Expired - Fee Related DE69530120T2 (de) 1994-12-30 1995-12-21 Verwendung von 2,3- alkylcaebonyloxybenzoesäure zur behandlung des atemunwohlseinsydroms bei erwachsenen

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69530120T Expired - Fee Related DE69530120T2 (de) 1994-12-30 1995-12-21 Verwendung von 2,3- alkylcaebonyloxybenzoesäure zur behandlung des atemunwohlseinsydroms bei erwachsenen

Country Status (7)

Country Link
US (1) US5504111A (de)
EP (2) EP1226821B1 (de)
JP (1) JPH10511953A (de)
AT (2) ATE337789T1 (de)
AU (1) AU4609096A (de)
DE (2) DE69535210T2 (de)
WO (1) WO1996020702A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5955496A (en) * 1996-08-13 1999-09-21 The Regents Of The University Of California Dihydroxy-oxy-eicosadienoates
US6174695B1 (en) 1997-08-12 2001-01-16 The Regents Of The University Of California Epoxide hydrolase inhibitor methods
AU2002368208A1 (en) * 2001-11-02 2004-05-04 Advanced Life Sciences, Inc. Use of 2,3 alkylcarbonyloxybenzoic acids in the treatment of anthrax
WO2004010989A1 (en) * 2002-07-25 2004-02-05 Advances Life Sciences, Inc. Use of 2,3 alkylcarbonyloxybenzoic acids, derivatives and analogues therefrom in the treatment of tissue and cellular dysfunction damage and injury in mammals

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4447451A (en) * 1981-07-20 1984-05-08 The Upjohn Manufacturing Company M Treatment of adult respiratory distress syndrome
US4443476A (en) * 1981-07-20 1984-04-17 The Upjohn Company Treatment of adult respiratory distress syndrome
DE3270988D1 (en) * 1981-07-20 1986-06-12 Upjohn Co Use of ibuprofen or flurbiprofen for the manufacture of a medicament for treating respiratory disorders
US4686100A (en) * 1985-04-02 1987-08-11 The Board Of Trustees Of The Leland Stanford Junior University Method for the treatment of adult respiratory distress syndrome
US4703040A (en) * 1985-04-03 1987-10-27 Markov Angel K Treatment of adult respiratory distress syndrome (ARDS) using fructose diphosphate (FDP)
US5198420A (en) * 1989-10-02 1993-03-30 The General Hospital Corporation Use of mullerian inhibiting substance and its agonists and antagonists in the treatment of respiratory distress syndrome
ES2113364T3 (es) * 1990-05-24 1998-05-01 Zeneca Ltd Agente terapeutico para el tratamiento y prevencion del sindrome de fatiga respiratoria en adultos.
JP2925391B2 (ja) * 1992-01-09 1999-07-28 サントリー株式会社 Ａｒｄｓ治療用医薬組成物
US5389522A (en) * 1993-03-19 1995-02-14 Repine; John E. Serum antioxidants as predictors of the adult respiratory distress syndrome in septic patients

Also Published As

Publication number Publication date
US5504111A (en) 1996-04-02
DE69530120T2 (de) 2004-02-05
WO1996020702A1 (en) 1996-07-11
DE69530120D1 (de) 2003-04-30
DE69535210T2 (de) 2007-08-02
EP0801563A1 (de) 1997-10-22
JPH10511953A (ja) 1998-11-17
AU4609096A (en) 1996-07-24
EP0801563B1 (de) 2003-03-26
ATE235238T1 (de) 2003-04-15
ATE337789T1 (de) 2006-09-15
EP1226821A3 (de) 2003-09-17
EP1226821A2 (de) 2002-07-31
EP1226821B1 (de) 2006-08-30

Similar Documents

Publication Publication Date Title
DE69103206T2 (de) Neue Derivate des Aminopiperidins, Aminopyrrolidins und des Aminoperhydroazepins, Verfahren zur Herstellung und diese enthaltende Arzneimittel.
NZ229787A (en) Amino ether diphosphonic acid derivatives and pharmaceutical compositions
DE59105815D1 (de) 1,4,7,10-Tetraazacyclododecan-butyltriole, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel.
ZA928170B (en) Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of alpha-D-neuraminic acid
ATE170510T1 (de) 3-(hydroxybenzylidenyl)-indolin-2-one und diese enthaltende arzneimittel
DE68922478D1 (de) Pyrazoloisoquinoline-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen.
ATE337789T1 (de) Pharmazeutische zusammensetzung enthaltend 2,3- alkylcarbonyloxybenzoesäure und ibuprofen
IL111580A (en) Use of melatonin derivatives in the preparation of pharmaceutical compositions for use in treating sleep disorders
ATE172976T1 (de) 3-aminochroman-spiroderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen
DK0505180T3 (da) Farmaceutisk præparat med højt indhold af ibuprofenlysinat
ATE135681T1 (de) Diclofenac-cholinsalz, verfahren zur herstellung und pharmazeutische zusammensetzungen, die es enthalten
DE68927055D1 (de) 2',5'-oligoadenylat-derivate zur verwendung als heilmittel
GR3017599T3 (en) Thiochromane derivatives, process for their preparation and pharmaceutical compositions containing them.
DE69412980D1 (de) Eburnan-Derivate, Verfahren zur ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
NO903291D0 (no) Renin-hemmende aminooligohydroksy-derivater.
HU900717D0 (en) Process for preparation of 3-pyroglutamyl-thyazolidine-4-carboxylic acid derivatives and pharmaceutical compositions containing that compounds
DE68905361D1 (de) Trienische derivate mit chromenischer struktur, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen.
MX9203900A (es) Composicion farmaceutica que comprende derivados de acido benzimidazolin-2-oxo-1-carboxilico.
HUT54682A (en) Process for producing 13-bromine- and 13,14-dibromine-ergoline derivatives and pharmaceutical preparatives containing these compounds
IL98199A (en) Pharmaceutical compositions containing a derivative of substituted l-valyl-l-prolinamide
DK0865422T3 (da) Anvendelse af aminoalkoholderivater som lægemidler, hidtil ukendte derivater og fremgangsmåde til fremstilling deraf
HU901631D0 (en) Process for the preparation of thienyl-piperazine derivatives and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
8381 Inventor (new situation)

Inventor name: FLAVIN, T., MICHAEL, DARIEN, IL 60561, US

Inventor name: NELSON, DEANNA J., RALEIGH, NC. 27607, US

Inventor name: BORGIA, F., JULIAN, DECEASED, US

Inventor name: JESMOK, J., GARY, MADISON, CT 06443, US

8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: KUDLEK & GRUNERT PATENTANWAELTE PARTNERSCHAFT, 803

8339 Ceased/non-payment of the annual fee